Treatment of patients of Vatarakta with Mustadi kwath

Assessment of efficacy of Mustadi kwath in Vatarakta: Randomised controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086232

Enrollment

Registered

2025-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E729- Disorder of amino-acid metabolism,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 20 to 60 2. Classical sign & symptoms of any type of vatarakta. 3. Patients of Hyperuricemia

Exclusion criteria

Exclusion criteria: 1. Patients with known cases of TB, Malignancy, HIV, Trauma, Cardiac disease, Neurological Disorders, Uncontrolled Diabetes Mellitus, Hypertension etc. 2. Pregnant and lactating mothers. 3. Diagnosed cases of rheumatoid arthritis, severe osteoarthritis and osteoporosis etc.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Mustadi Kwath in treatment of Vatarakta.Timepoint: Assessment will be Regular follow up On 0th, 2nd , 4th , 6th, 8th week.	—

Secondary

Measure	Time frame
1. To review literature about Vatarakta & Kwath Kalpana from various Samhita s. 2. To review literature about Gout from various Modern Medicine books. 3. To evaluate the efficacy of Vasadi Kwath in treatment of Vatarakta. 4. To compare the efficacy of Mustadi Kwath & Vasadi Kwath in the management of Vatarakta. 5. To observe adverse drug reaction if any occurs.Timepoint: Assessment will be Regular follow up On 0th, 2nd , 4th , 6th, 8th week.	—

Measure

Time frame

1. To review literature about Vatarakta & Kwath Kalpana from various Samhita s. 2. To review literature about Gout from various Modern Medicine books. 3. To evaluate the efficacy of Vasadi Kwath in treatment of Vatarakta. 4. To compare the efficacy of Mustadi Kwath & Vasadi Kwath in the management of Vatarakta. 5. To observe adverse drug reaction if any occurs.Timepoint: Assessment will be Regular follow up On 0th, 2nd , 4th , 6th, 8th week.

—

Countries

India

Contacts

Public ContactDr Sandeep Shinde

PMT s Ayurved College Shevgaon, Ahmednagar

vd.sandeepshinde@gmail.com9405766631

Outcome results